PAR 1.67% 30.5¢ paradigm biopharmaceuticals limited..

Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-261

  1. 599 Posts.
    lightbulb Created with Sketch. 109
    Me too,@Werble. I accept that others have legitimate concerns, though. Many here seem to know a lot more about science and/or stock markets than I do, but I look at what other 'speculative' pre-revenue stocks on my watchlist have done and they have been erratic and unpredictable - even with tangible, proven assets such as in mining. I'm down around 50% on my PAR holding, have been down for years, but I'm still excited and optimistic.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
30.5¢
Change
0.005(1.67%)
Mkt cap ! $106.6M
Open High Low Value Volume
30.5¢ 31.5¢ 29.5¢ $152.7K 501.9K

Buyers (Bids)

No. Vol. Price($)
2 16864 30.5¢
 

Sellers (Offers)

Price($) Vol. No.
31.5¢ 20426 2
View Market Depth
Last trade - 16.10pm 17/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.